Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 24, 2014	Sep. 25, 2013
Cash flows from operating activities:
Net income	$ 23,047	$ 20,310
Adjustments to reconcile net income to cash flows provided by operating activities:
Depreciation and amortization	15,704	15,774
Operating (gains), losses and other charges, net	1,049	1,779
Amortization of deferred financing costs	362	376
(Gain) loss on early extinguishments of debt	(54)	1,798
Loss on change in the fair value of interest rate caps	11	28
Deferred income tax expense	8,118	8,241
Share-based compensation	2,993	3,434
Decrease (increase) in assets:
Receivables	2,325	3,519
Inventories	138	0
Other current assets	1,089	2,291
Other assets	(1,668)	(1,399)
Increase (decrease) in liabilities:
Accounts payable	1,797	(3,461)
Accrued salaries and vacations	(620)	(3,089)
Accrued taxes	1,753	1,823
Other accrued liabilities	(5,437)	(4,015)
Other noncurrent liabilities and deferred credits	(2,366)	(2,693)
Net cash flows provided by operating activities	48,241	44,716
Cash flows from investing activities:
Capital expenditures	(17,880)	(9,461)
Acquisition of restaurant and real estate	0	(3,980)
Proceeds from disposition of property	61	1,591
Collections on notes receivable	1,788	3,653
Issuance of notes receivable	(1,167)	(1,232)
Net cash flows used in investing activities	(17,198)	(9,429)
Cash flows from financing activities:
Net revolver borrowings under new credit agreement	1,750	97,000
Term loan borrowings under new credit agreement	0	60,000
Long-term debt payments	(5,340)	(174,820)
Proceeds from exercise of stock options	970	2,077
Tax withholding on share-based payments	(419)	(464)
Tax benefit (expense) for share-based compensation	627	(204)
Debt transaction costs	0	366
Deferred financing costs	0	1,372
Purchase of treasury stock	(32,073)	(21,952)
Net bank overdrafts	1,949	(2,421)
Net cash flows used in financing activities	(32,536)	(42,522)
Decrease in cash and cash equivalents	(1,493)	(7,235)
Cash and cash equivalents at beginning of period	2,943	13,565
Cash and cash equivalents at end of period	$ 1,450	$ 6,330